1.
Conclusion Heparin could make PLT and MPV decreased, especially in UFH group.
结论肝素抗凝可致PLT及MPV下降,UFH尤其显著;
2.
The Impact of Hemorrhage and Coagulation on the Use of Low-molecular-weight Heparin Started at Earlier Period after Lung Resection
肺叶切除术后早期使用低分子肝素抗凝对出血及凝血功能的影响
3.
Heparinized Plasma Compared With Serum Samples for Measurement of Routine Biochemistry Indicators
肝素抗凝血浆与血清的常规生化指标检测结果比较
4.
Nursing Care for Patients at High Risk of Hemorrhage Treated with Heparin-free Anti-coagulation in Continuous Renal Replacement
高危出血患者无肝素抗凝连续性肾替代治疗的护理
5.
The effect of regional heparin anticoagulation in continuous blood purification in patients with high risk of bleeding
局部肝素抗凝在高危出血倾向患者连续性血液净化中的应用
6.
Objective To study pre-thrombosis state in patients with cor pulmonale and analyze the value of treatment with low molecular heparin (LMH).
目的 探讨肺心病患者的血栓前状态 ,并观察分析低分子肝素抗凝干预的价值 ;
7.
Methods :Clinical blood tumor samples were se parated to obtain mononuclear cells by Ficoll-Hypaque,solid tumor tissues were made to be single c ells by using mechanical method.
方法:血液肿瘤取肝素抗凝外固血或骨髓样本,用淋巴细胞分层液分离纯化单个核细胞;
8.
Heparin is the most widely used and reliable anticoagulant.
肝素为最广泛应用及最可靠的抗凝剂。
9.
Low molecular weight heparin in anticoagulation during hemodialysis
低分子肝素在血液透析抗凝中的应用
10.
Nonanticoagulant Heparin Inhibits B16F10 Metastasis
低抗凝血肝素抑制B16F10转移
11.
The effects of prophylactic heparin on acute lung injury coagulopathy in endotoxemic rats
肝素早期抗凝对内毒素致急性肺损伤大鼠凝血功能的影响
12.
Heparin anticoagulant therapy for pregnant women with postpartum hemorrhage volume of clinical analysis
肝素钠抗凝治疗与孕妇产后出血量的临床分析
13.
Effects of dalteparin and unfractionated heparin on plasma anti-Xa activity and activated clotting time during elective percutaneous coronary intervention or coronary angiography
达肝素与普通肝素对血浆抗凝血因子Ⅹa活性及活化凝血时间影响的对比研究
14.
Effect of homemade low molecular weight heparin on hemodialysis
国产相对低分子质量肝素在血液透析中的抗凝疗效
15.
THE EFFECT ON ANTICOAGULANT ACTIVITY OF HEPARIN SODIUM AND CALCIUM SALT BY ACID HYDROLYSIS IN MILD CONDITION
温和条件下酸水解对肝素钠盐和钙盐抗凝血活性的影响
16.
A prospective trial that demon strates that dalteparin requirements increase i n pregnan-cy to maintain therapeutic levels of anticoag-ulation
前瞻性试验表明:妊娠期需增加达肝素用量以保持抗凝治疗的水平
17.
Study on the Synthesis of Heparinoid Derivatives of Chitosan and the Determination of Their Antothrombogenicities;
壳聚糖类肝素衍生物的合成及其抗凝血性能研究
18.
Preparation of Heparin Modified Gold Nanoparticles and Its Application in Detecting Antithrombin Ⅲ
肝素金纳米粒子的制备及其对抗凝血酶Ⅲ（ATⅢ）的识别